Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, Bottiroli M, Mondino M, Merli M, Bellone A, Basile A, Ruggeri R, Colombo F, Moreno M, Pastori S, Perno CF, Tarsia P, Epis OM, Puoti M; Niguarda COVID-19 Working Group.
Rossotti R, et al. Among authors: perno cf.
J Infect. 2020 Oct;81(4):e11-e17. doi: 10.1016/j.jinf.2020.07.008. Epub 2020 Jul 8.
J Infect. 2020.
PMID: 32652164
Free PMC article.